Acrospire Investment Management’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-296
Closed -$6K 144
2017
Q2
$6K Buy
296
+100
+51% +$2.06K 0.01% 1919
2017
Q1
$4K Sell
196
-400
-67% -$8.42K ﹤0.01% 2036
2016
Q4
$13K Sell
596
-5,404
-90% -$95.5K 0.01% 1891
2016
Q3
$92K Buy
6,000
+5,300
+757% +$69.4K 0.06% 619
2016
Q2
$8K Sell
700
-1,300
-65% -$16.2K 0.01% 1789
2016
Q1
$26K Buy
+2,000
New +$25.5K 0.02% 1399

Other funds holding BAK

Acrospire Investment Management's BAK Position: Q3 2017 in Review

Acrospire Investment Management sold out of Braskem (BAK) in Q3 2017, closing a stake of 296 shares — an estimated $6K sold.

Acrospire Investment Management first reported a position in BAK in Q1 2016 and held it in 6 quarters. The position peaked at $92K in Q3 2016. 90 funds tracked by Wall St. Rank hold BAK as of Q3 2017.

  • Acrospire Investment Management reported no remaining Braskem position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 296 Braskem shares in Q3 2017, an estimated $6K.
  • Acrospire Investment Management first reported a position in Braskem in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Braskem position peaked at $92K in Q3 2016.
  • 90 funds tracked by Wall St. Rank held Braskem as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.